Shareholder rights law firm Johnson & Weaver, LLP has commenced an investigation into whether certain officers and directors of Aegerion Pharmaceuticals, Inc. (Nasdaq: AEGR) violated state or federal laws.
On October 31, 2014, Aegerion stock dropped abruptly when the biopharmaceutical company announced downward revisions to its 2014 full year guidance. Since this news announcement, Aegerion shares have fallen over 40% in late day trading. Specifically, Johnson & Weaver’s investigation seeks to determine whether prior statements regarding the Company’s business and prospects were false and misleading when made.
If you have information that could assist in this investigation, or if you are an Aegerion shareholder and are interested in learning more about the investigation or your legal rights and remedies, please contact Jim Baker (jimb@johnsonandweaver.com) by email or by phone at 619-814-4471.
About Johnson & Weaver, LLP:
Johnson & Weaver, LLP is a nationally recognized shareholder rights law firm with offices in California and New York. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit http://www.johnsonandweaver.com. Attorney advertising. Past results do not guarantee future outcomes.
Contacts:
Jim Baker, 619-814-4471
jimb@johnsonandweaver.com
